Pelthos Therapeutics Stock Market Value
| PTHS Stock | 26.50 0.48 1.78% |
| Symbol | Pelthos |
Pelthos Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pelthos Therapeutics. If investors know Pelthos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pelthos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pelthos Therapeutics is measured differently than its book value, which is the value of Pelthos that is recorded on the company's balance sheet. Investors also form their own opinion of Pelthos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pelthos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pelthos Therapeutics' market value can be influenced by many factors that don't directly affect Pelthos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pelthos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pelthos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pelthos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pelthos Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pelthos Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pelthos Therapeutics.
| 11/24/2025 |
| 12/24/2025 |
If you would invest 0.00 in Pelthos Therapeutics on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Pelthos Therapeutics or generate 0.0% return on investment in Pelthos Therapeutics over 30 days. Pelthos Therapeutics is related to or competes with CASI Pharmaceuticals, Lisata Therapeutics, Kairos Pharma,, Lexaria Bioscience, Passage Bio, Lixte Biotechnology, and Enlivex Therapeutics. Pelthos Therapeutics is entity of United States More
Pelthos Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pelthos Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pelthos Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 28.36 | |||
| Value At Risk | (8.07) | |||
| Potential Upside | 8.62 |
Pelthos Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pelthos Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pelthos Therapeutics' standard deviation. In reality, there are many statistical measures that can use Pelthos Therapeutics historical prices to predict the future Pelthos Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.11) |
Pelthos Therapeutics Backtested Returns
Pelthos Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.032, which implies the firm had a -0.032 % return per unit of risk over the last 3 months. Pelthos Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pelthos Therapeutics' Coefficient Of Variation of (3,266), risk adjusted performance of (0.01), and Variance of 29.74 to confirm the risk estimate we provide. The company holds a Beta of 1.57, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pelthos Therapeutics will likely underperform. At this point, Pelthos Therapeutics has a negative expected return of -0.18%. Please make sure to check Pelthos Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Pelthos Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.07 |
Virtually no predictability
Pelthos Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Pelthos Therapeutics time series from 24th of November 2025 to 9th of December 2025 and 9th of December 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pelthos Therapeutics price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Pelthos Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | -0.45 | |
| Residual Average | 0.0 | |
| Price Variance | 3.18 |
Pelthos Therapeutics lagged returns against current returns
Autocorrelation, which is Pelthos Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pelthos Therapeutics' stock expected returns. We can calculate the autocorrelation of Pelthos Therapeutics returns to help us make a trade decision. For example, suppose you find that Pelthos Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pelthos Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pelthos Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pelthos Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pelthos Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Pelthos Therapeutics Lagged Returns
When evaluating Pelthos Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pelthos Therapeutics stock have on its future price. Pelthos Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pelthos Therapeutics autocorrelation shows the relationship between Pelthos Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Pelthos Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.